Chemoinformaics analysis of 2,3,6-Tri-O-methyl-D-mannose
| Molecular Weight | 222.237 | nRot | 8 |
| Heavy Atom Molecular Weight | 204.093 | nRig | 1 |
| Exact Molecular Weight | 222.11 | nRing | 0 |
| Solubility: LogS | 0.216 | nHRing | 0 |
| Solubility: LogP | -1.183 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 31.8443 |
| nHD | 2 | BPOL | 24.1337 |
| QED | 0.49 |
| Synth | 4.191 |
| Natural Product Likeliness | 1.604 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.664 |
| HIA | 0.679 |
| CACO-2 | -4.988 |
| MDCK | 0.000118713 |
| BBB | 0.149 |
| PPB | 0.246808 |
| VDSS | 0.496 |
| FU | 0.780439 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.711 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.389 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.035 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.132 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.095 |
| CL | 3.573 |
| T12 | 0.695 |
| hERG | 0.106 |
| Ames | 0.21 |
| ROA | 0.013 |
| SkinSen | 0.839 |
| Carcinogencity | 0.016 |
| EI | 0.842 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.39 |
| Antiviral | No |
| Prediction | 0.844863 |